Mesoblast (MESO) EBIT Margin (QoQ) (2014 - 2023)
Mesoblast (MESO) EBIT Margin (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -79,029.00 |
| Mar 31, 2023 | 49,657.00 |
| Dec 31, 2022 | -9,178.00 |
| Sep 30, 2022 | -56,264.00 |
| Jun 30, 2022 | 42,187.00 |
| Mar 31, 2022 | 47,065.00 |
| Dec 31, 2021 | -12,155.00 |
| Sep 30, 2021 | 13,806.00 |
| Jun 30, 2021 | 25,280.00 |
| Mar 31, 2021 | -19,253.00 |
| Dec 31, 2020 | 67,094.00 |
| Sep 30, 2020 | -157,111.00 |
| Jun 30, 2020 | 58,326.00 |
| Mar 31, 2020 | 53,285.00 |
| Dec 31, 2019 | -97,578.00 |
| Sep 30, 2019 | 118,410.00 |
| Jun 30, 2019 | 91,707.00 |
| Mar 31, 2019 | 15,514.00 |
| Dec 31, 2018 | -37,353.00 |
| Sep 30, 2018 | -71,956.00 |